4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the stock will go up." And while that proposition is certainly true with Viking Therapeutics, (NASDAQ: VKTX) there's more than one reason for why the stock is worth buying.In fact, there are at least four arguments supporting an investment, so let's take a look at each.Viking is still in the process of getting its first medicine out the door. By the looks of it, things are proceeding as planned, and within a couple of years at most, it'll be raking in sales, which is a reason to buy its stock.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool